Bio-Rad Laboratories

Bio-Rad, a global leader in supporting healthcare, provides the industry with useful products and services spanning the entire range of drug discovery and development activities from target identification to scale-up and manufacturing. With a team of 7800 employees and a global network of operations, Bio-Rad is among the top five life science companies worldwide offering a wide range of instruments, software, and reagents for the growing fields of cell biology, gene expression, protein purification, and protein quantitation.

For researchers, this has meant offering products and solutions that simplify processes and improve methods and materials, thus enabling the acceleration of the discovery process. It all adds up to a place built on the values of innovation, involvement, independence, and integrity where we feel the greatest sense of personal satisfaction knowing that, together and as individuals, we are making a difference, helping people lead longer, healthier lives.

Article: Understanding potency in cell and gene therapy development

Article: Challenges in developing CAR T-cell therapies

Infographic: Detecting Mycoplasma contamination in your cell culture with confidence

Whitepaper: CAR T-Cell analysis with modular antibodies using SpyTag protein ligation

Bulletin: Cancer vaccines: getting ready for a decade of big breakthroughs and novel treatments

Infographic: Overview of the CAR-T cell therapy workflow

Bulletin: Utilising the multiparameter capability of the Ze5 Cell Analyser to monitor T cell exhaustion and effects of immunotherapy

Whitepaper: Discriminating copy number variation from heterogeneous samples using the S3™ Cell Sorter and the QX200™ Droplet Digital™ PCR System

Whitepaper: Isolation of stably transfected fluorescent cells with the S3™ Cell Sorter

Whitepaper: Uncover specific correlations in heterogeneous cell populations during drug development

Whitepaper: Development and Validation of Bio-Plex Pro™ Human Chemokine Assays

Whitepaper: Applications of Bio-Plex Pro™ cell signaling Akt and MAPK assay panels in signal transduction pathways

Optimised antibody panels for CTC and rare cell enumeration

Antibody pipelines – the pharma perspective

Providing new hope for rare disease using non-viral gene therapy

The promise of cell therapy: scaling up a new treatment paradigm for hearing loss

Challenges and opportunities: lessons learned in developing potential gene therapy cures

Leveraging a dual technology platform to develop gene therapies for a range of rare diseases

Drug Target Review Cell & Gene Therapy ebook

Expert view: ddPCR whole cell DNA workflow efficiently measures success of CAR T-cell production

Expert view: Bio-Rad’s comprehensive genomics portfolio provides answers for every problem

Expert view: Generate high‑content information using flow cytometry

Flow Cytometry In-Depth Focus 2018

Expert view: A technological breakthrough in flow cytometry

NGS In-Depth Focus 2017

Expert view: The future of single-cell sequencing

Lab automation market set to increase at CAGR of seven percent

Label-free array system market to be worth $1,600 million by 2025, study finds

Video: Did you know that ddPCR technology offers lower variability for viral titer determination?

Podcast: Challenges for the bioanalysis of CAR-T Cells

Video: Anti-Idiotypic antibodies for development of CAR T cell therapies

Developing next generation non-replicative HSV-1 vectors for sustainable and more precise gene therapies

Turning Plans into Reality: Real Examples of Custom Automation Projects